Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.

Carrascosa, J M; Vilavella, M; Garcia-Doval, I; Carretero, G; Vanaclocha, F; Daudén, E; Gómez-García, F J; Herrera-Ceballos, E; De la Cueva Dobao, P; Belinchón, I; Sánchez-Carazo, J L; Alsina, M; López-Estebaranz, J L; Ferrán, M; Peral, F; Torrado, R; Rivera, R; Jiménez-Puya, R; Mendiola, M V; Ferrándiz, C

Carrascosa, J M; Vilavella, M; Garcia-Doval, I; Carretero, G; Vanaclocha, F; Daudén, E; Gómez-García, F J; Herrera-Ceballos, E; De la Cueva Dobao, P; Belinchón, I; Sánchez-Carazo, J L; Alsina, M; López-Estebaranz, J L; Ferrán, M; Peral, F; Torrado, R; Rivera, R; Jiménez-Puya, R; Mendiola, M V; Ferrándiz, C.

Affiliation

Carrascosa JM; Hospital Universitari Germans Trías i Pujol, Badalona, Universitat Autònoma de Barcelona, Barcelona.

J Eur Acad Dermatol Venereol ; 28(7): 907-14, 2014 Jul.

Article in En | MEDLINE | ID: mdl-23848131

Subject(s)

Biological Products/adverse effects; Biological Products/therapeutic use; Body Mass Index; Obesity/complications; Obesity/epidemiology; Psoriasis/drug therapy; Severity of Illness Index; Withholding Treatment; Comorbidity; Humans; Multivariate Analysis; Overweight/complications; Overweight/epidemiology; Prevalence; Prospective Studies; Psoriasis/epidemiology; Registries; Risk Factors; Spain/epidemiology; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Psoriasis / Biological Products / Severity of Illness Index / Body Mass Index / Withholding Treatment / Obesity Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google